HCPCS Level IIdrugActive
J9054
Inj bortezomib boruzu 0.1 mg
BETOS: O1D
Effective: 2025-04-01
Referenced in 1 policies
Description
Injection, bortezomib (boruzu), 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Boruzu
Manufacturer
Amneal Pharmaceuticals, LLC
HCPCS Dosage
0.1 MG
Billing Units
35.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.